VIVALDI project

VIVALDI (Preventing and Mitigating Farmed Bivalve Diseases) is a European scientific project, financed in the framework of the EU Research and Development programme called Horizon 2020. It is carried out by a consortium of 21 partners, from 10 countries. It will last 4 years, till February 2020. VIVALDI’s overarching purpose is to increase the sustainability and competitiveness of the European shellfish industry. For this, it will aim at improving the understanding of the diseases and developing practical solutions to prevent, control and manage them. The main species to be studied will be: oysters, mussels, clams and scallops.

Latest news

Stakeholders workshop, 29 August 2018

Published on 19 march

On 29 August 2018, in the framework of Aqua 2018 in Montpellier (F), the VIVALDI consortium will organise an open workshop entitled “Acting together to better prevent and mitigate farmed bivalve diseases”.

Recent publications related to VIVALDI

Published on 15 february

In 2017 and early 2018, Italian and French researchers involved in VIVALDI have published 4 articles emphasising some first scientific results notably obtained thanks to our project.

First results of the project!

Published on 30 january

Progress has been achieved in understanding, preventing and mitigating shellfish diseases. More results will come soon.

VIVALDI General Assembly 2018

Published on 15 january

The 2018 General Assembly of the VIVALDI project will take place from 6 to 8 March 2018, in Weymouth (UK), at the kind invitation of CEFAS.

IMR and Cefas held a collaborative meeting at Cefas Weymouth laboratory, on 23-25 August 2017

Published on 15 january

This visit was organised as part of Vivaldi work on pathogen diversity and improving tools for better surveillance.


Want to test your knowledge about shellfish? Try this quizz and share your results with your friends and colleagues.


Isabelle Arzul

IFREMER La Tremblade
05 46 76 26 47

This project has received funding from the European Union’s Horizon 2020 Research and innovation programme under grant agreement N° 678589